Robert Lutz

Robert Lutz

Company: Iksuda

Job title: Chief Science Officer


Advanced ADC Design Shows Marked Increase in Therapeutic Index for Powerful DNA-targeting Payloads 11:30 am

• Tumor-selective linker and prodrug technology leads to improved toxicity profiles and therapeutic margins for high potency ADC payloads • Case study: Moving IKS03, a best-in-class CD19-targeting ADC with tumor-selective technology, toward the clinicRead more

day: day 1 track 2 am

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.